Improving real production capacity and export potential of “Adipharm” EAD

Adipharm EAD is a company incorporated and registered in Sofia in 1994 with scope of business– production and trade of pharmaceutical and chemical products.The accumulated traditions and experience for two decades in the branch turned Adipharm into one of the biggest pharmaceutical companies in Bulgaria, producing a wide range of medicines and food additives.TheCompany works in an active cooperation with leading world pharmaceutical companies, which it has contracts for joint manufacture and supplies with.The main aspiration of theFirm has always been related to the creation of products of quality,efficient and useful,accessible for each patient.By this project proposal Adipharm strives to attain its medium-term and long-term objectives related to the improvement of the efficiency of the production,the development and manufacture of new medicines,the introduction of new technologies for effective,efficient and safe medicines,enhancement of the competitive advantages and expansion of the export potential of theFirm.The project strives to meet the general objective of OP“Innovations and Competitiveness”,namely– development of economy,competitive on the European and global market.For the attainment of this objective,the project proposal anticipates the purchase of new machines which will result in the increase of the production capacity and the enhancement of the efficiency and the quality of the production.Thus theCompany will have possibility to offer new products on the market conformed to the global tendencies and requirements for quality and efficiency in the sphere of pharmacy.Along with the increase of the production capacities and the improvement of the processes,the quality control,the efficiency and the safety of the medicines will be increased.The equipment anticipated in the project is of the most modern type and fully satisfies the requirements from sphere “Industry for a Healthy Life and Bio-Technology” of the InnovationStrategy for SmartSpecialization.

Comments
Leave a comment

Overview

Status Closed (completion date)
Start date 09 Feb, 2016
End date 24 Nov, 2017
Contract date 09 Feb, 2016
View in UMIS

Beneficiary

Financial information

Total cost 2,832,474.08
Grant 991,365.93
Self finance 1,841,108.15
Total paid 852,922.47
EU participation percent 85.0%

Location